University of Rijeka Faculty of Biotechnology and Drug Development
Cite this document
Vukušić, K. (2016). Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling (Master's thesis). Rijeka: University of Rijeka. Retrieved from https://urn.nsk.hr/urn:nbn:hr:193:483208
Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Master's thesis, University of Rijeka, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208
Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Master's thesis, University of Rijeka, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208
Vukušić, K. (2016). 'Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling', Master's thesis, University of Rijeka, accessed 15 September 2024, https://urn.nsk.hr/urn:nbn:hr:193:483208
Vukušić K. Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling [Master's thesis]. Rijeka: University of Rijeka; 2016 [cited 2024 September 15] Available at: https://urn.nsk.hr/urn:nbn:hr:193:483208
K. Vukušić, "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling", Master's thesis, University of Rijeka, Rijeka, 2016. Available at: https://urn.nsk.hr/urn:nbn:hr:193:483208